Authors:
OREILLY LA
CULLEN L
MORIISHI K
OCONNOR L
HUANG DCS
STRASSER A
Citation: La. Oreilly et al., RAPID HYBRIDOMA SCREENING METHOD FOR THE IDENTIFICATION OF MONOCLONAL-ANTIBODIES TO LOW-ABUNDANCE CYTOPLASMIC PROTEINS, BioTechniques, 25(5), 1998, pp. 824
Citation: Dcs. Huang et al., THE CONSERVED N-TERMINAL BH4 DOMAIN OF BCL-2 HOMOLOGS IS ESSENTIAL FOR INHIBITION OF APOPTOSIS AND INTERACTION WITH CED-4, EMBO journal, 17(4), 1998, pp. 1029-1039
Citation: Dcs. Huang et al., BCL-2, BCL-X(L) AND ADENOVIRUS PROTEIN E1B19KD ARE FUNCTIONALLY EQUIVALENT IN THEIR ABILITY TO INHIBIT CELL-DEATH, Oncogene, 14(4), 1997, pp. 405-414
Citation: A. Strasser et al., THE ROLE OF THE BCL-2 CED-9 GENE FAMILY IN CANCER AND GENERAL IMPLICATIONS OF DEFECTS IN CELL-DEATH CONTROL FOR TUMORIGENESIS AND RESISTANCE TO CHEMOTHERAPY/, Biochimica et biophysica acta, CR. Reviews on cancer, 1333(2), 1997, pp. 151-178
Citation: Dcs. Huang et al., THE ANTI-APOPTOSIS FUNCTION OF BCL-2 CAN BE GENETICALLY SEPARATED FROM ITS INHIBITORY EFFECT ON CELL-CYCLE ENTRY, EMBO journal, 16(15), 1997, pp. 4628-4638
Citation: La. Oreilly et al., THE CELL-DEATH INHIBITOR BCL-2 AND ITS HOMOLOGS INFLUENCE CONTROL OF CELL-CYCLE ENTRY, EMBO journal, 15(24), 1996, pp. 6979-6990